Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| EG00229 | C19H20F3N7O7S3 | 1210945-69-9 | Details |
| Ecopladib | C39H33Cl3N2O5S | 381683-92-7 | Details |
| Aldoxorubicin；DOXO-EMCH;INNO-206 | C37H42N4O13 | 1361644-26-9 | Details |
| DSR-6434 | C19H28N8O2 | 1059070-10-8 | Details |
| DPBQ | C24H14N2O2 | 7029-89-2 | Details |
| E-7386 | C39H48FN9O4 | 1799824-08-0 | Details |
| DS88790512 | C22H29N3O2 | 2231089-95-3 | Details |
| EGFR-IN-7 | C32H41BrN9O2P | 2267329-76-8 | Details |
| Ciclopirox olamine | C14H24N2O3 | 41621-49-2 | Details |
| E64FC26 | C19H23F3O2 | 2285446-62-8 | Details |
| DuP 105 | C13H16N2O4S | 96800-41-8 | Details |
| Dutogliptin；PHX-1149 free base | C10H20BN3O3 | 852329-66-9 | Details |
| Duocarmycin MB | C27H26ClN3O4 | 1613286-58-0 | Details |
| Nazartinib S-enantiomer；EGF816 (S-enantiomer) | C26H31ClN6O2 | 1508256-20-9 | Details |
| Dutogliptin tartrate；PHX-1149 | C14H26BN3O9 | 890402-81-0 | Details |
| Dot1L-IN-2 | C27H24N8O | 1940206-71-2 | Details |
| Dofetilide D4；UK 68789 D4 | C19H27N3O5S2 | 1189700-56-8 | Details |
| (Z)-Capsaicin | C18H27NO3 | 25775-90-0 | Details |
| DVD-445 | C25H28F2N2O4 | 2375846-41-4 | Details |
| Deschloroclozapine | C18H20N4 | 1977-07-7 | Details |
| DUB-IN-2 | C15H9N5O | 924296-19-5 | Details |
| Droloxifene | C26H29NO2 | 82413-20-5 | Details |
| Doxepin D3 Hydrochloride | C19H19ClD3NO | 347840-07-7 | Details |
| DUPA(OtBu)-OH | C23H40N2O9 | 1026987-94-9 | Details |
| DRAK2-IN-1 | C21H20N4O3 | 871837-60-4 | Details |
| EGFR-IN-2 | C26H33N9O3S | 1643497-70-4 | Details |
| DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
| Dopropidil | C20H35NO2 | 79700-61-1 | Details |
| DU717 | C12H15ClN4O2S | 59943-31-6 | Details |
| 2-(Hydroxymethyl)pyridine | C6H7NO | 586-98-1 | Details |
| DOV-216,303 Free Base | C11H11Cl2N | 66504-40-3 | Details |
| Biotin | C10H16N2O3S | 58-85-5 | Details |
| Ecteinascidin-Analog-1 | C31H44N2O9 | 874758-58-4 | Details |
| Ecteinascidin 770；Et-770;Ecteinascidine 770 | C40H42N4O10S | 114899-80-8 | Details |
| EACC | C13H11N3O6S2 | 864941-31-1 | Details |
| Duocarmycin MA | C34H31ClN4O5 | 1613286-57-9 | Details |
| EHMT2-IN-1 | C18H23N7O | 2230849-55-3 | Details |
| (E/Z)-BCI | C22H23NO | 15982-84-0 | Details |
| DW14800 | C31H36N4O3 | 2243709-60-4 | Details |
| EB-47 | C24H27N9O6 | 366454-36-6 | Details |
| EC1454 | C65H98N16O34S | 1602487-15-9 | Details |
| Eg5 Inhibitor V, trans-24 | C26H21N3O3 | 869304-55-2 | Details |
| Nithiamide | C5H5N3O3S | 140-40-9 | Details |
| DUB-IN-1 | C20H11N5O | 924296-18-4 | Details |
| Imazalil | C14H14Cl2N2O | 35554-44-0 | Details |
| Duocarmycin DM free base；Duocarmycin | C26H26ClN3O3 | 1116745-06-2 | Details |
| Duocarmycin TM | C25H23ClN2O5 | 157922-77-5 | Details |
| DOTAP chloride | C42H80ClNO4 | 132172-61-3 | Details |
| EC5026 | C18H23F4N3O3 | 1809885-32-2 | Details |
| Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
| DYRKs-IN-1 | C30H30ClN7O4 | 1387090-01-8 | Details |
| MC-DOXHZN；Doxorubicin(6-maleimidocaproyl)hydrazone | C37H42N4O13 | 151038-96-9 | Details |
| DREADD agonist 21 | C17H18N4 | 56296-18-5 | Details |
| DZ2002 | C10H13N5O3 | 33231-14-0 | Details |
| Duocarmycin GA | C26H25ClN4O3 | 1613286-59-1 | Details |
| Duvelisib (R enantiomer)；INK1197 R enantiomer;Duvelisib R enantiomer;IPI-145 R enantiomer | C22H17ClN6O | 1261590-48-0 | Details |
| Dofetilide N-oxide；UK-116856 | C19H27N3O6S2 | 144449-71-8 | Details |
| DRI-C21045 | C32H24N2O7S | 2101765-81-3 | Details |
| Durlobactam sodium salt | C8H12N3NaO6S | 1467157-21-6 | Details |
| LHF-535 | C27H28N2O2 | 1450929-77-7 | Details |
| EGFR-IN-8 | C32H23ClF3N7O4 | 2407957-87-1 | Details |
| Dooku1 | C13H9Cl2N3OS | 2253744-54-4 | Details |
| DSP-0565 | C14H12FNO | 1226855-28-2 | Details |
| Duocarmycin SA | C25H23N3O7 | 130288-24-3 | Details |
| DUB-IN-3 | C16H9N5O | 924296-17-3 | Details |
| EGFR-IN-9 | C29H24N4O3 | 1226549-39-8 | Details |
| Dolutegravir intermediate-1 | C13H17NO8 | 1335210-23-5 | Details |
| (E)-GABAB receptor antagonist 1 | C18H24O4 | 1611483-29-4 | Details |
| EGFR-IN-1 | C28H30N6O4 | 1625677-63-5 | Details |
| Duoperone | C28H26F4N2OS | 62030-88-0 | Details |
| Doxylamine D5 succinate | C21H28N2O5 | 1216840-94-6 | Details |
| (E)-10-Hydroxynortriptyline maleate；(E)-10-Hydroxy Nortriptyline maleate | C23H25NO5 | 74853-74-0 | Details |
| Drobuline hydrochloride | C19H26ClNO | 68162-52-7 | Details |
| DS-1040 Tosylate | C23H35N3O5S | 1335138-89-0 | Details |
| E6130 | C28H37ClF3N3O3 | 1427058-33-0 | Details |
| EC359 | C36H38F2O2 | 2012591-09-0 | Details |
| EG01377 | C26H30N6O6S2 | 2227996-00-9 | Details |
| DS21360717 | C21H23N7O | 2304654-43-9 | Details |
| DYRKs-IN-2 | C32H38ClN9O3 | 1386980-04-6 | Details |
| Duramycin；Moli1901;Lancovutide | C89H125N23O25S3 | 1391-36-2 | Details |
| EGLU | C7H13NO4 | 170984-72-2 | Details |
| Durvalumab | 1428935-60-7 | Details |
| Nazartinib mesylate；EGF816 (mesylate) | C27H35ClN6O5S | 1508250-72-3 | Details |
| Pralidoxime Chloride | C7H9ClN2O | 51-15-0 | Details |
| DSP-1053 | C26H32BrNO4 | 1176326-76-3 | Details |
| EGFR-IN-5 | C31H38FN9O | 2225887-26-1 | Details |
| EC0488 | C65H98N16O34S | 1059477-92-7 | Details |
| DPPH | C18H12N5O6* | 1898-66-4 | Details |
| Duloxetine D3 hydrochloride；LY248686 D3 hydrochloride;(S)-Duloxetine D3 hydrochloride | C18H20ClNOS | 1435727-97-1 | Details |
| Ecastolol | C26H33N3O6 | 77695-52-4 | Details |
| NMI 8739 | C30H41NO3 | 129024-87-9 | Details |
| Droxicainide | C16H24N2O2 | 78289-26-6 | Details |
| Donitriptan | C23H25N5O2 | 170912-52-4 | Details |
| Duloxetine metabolite Para-Naphthol Duloxetine；Para-Naphthol duloxetine | C18H19NOS | 949095-98-1 | Details |
| Meclizine dihydrochloride | C25H29Cl3N2 | 1104-22-9 | Details |
| Doxylamine succinate | C21H28N2O5 | 562-10-7 | Details |
| Edaravone-d5；MCI-186 D5;Edaravone D5 | C10H10N2O | 1228765-67-0 | Details |
| Dot1L-IN-1 | C32H36ClN9O2S | 2088518-50-5 | Details |
| DS18561882 | C28H31F3N4O6S | 2227149-22-4 | Details |
| EGFR-IN-1 hydrochloride | C28H31ClN6O4 | 2227455-78-7 | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | ||||